FDA Approves Mycamine
Mycamine Approved for Candida Infections
Mycamine (micafungin sodium) is a member of a new class of antifungal agents, the echinocandins, which inhibit cell-wall synthesis. Mycamine is used for the prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation and the treatment of esophageal candidiasis.Posted: March 2005
Related Articles:
- FDA Approves Additional Indication for Astellas' Mycamine - January 23, 2008
- Fujisawa Healthcare, Inc. Submits NDA For Mycamine For Treatment Of Esophageal Candidiasis - April 27, 2004
